An official website of the United States government
Here's how you know
A .mil website belongs to an official U.S. Department of Defense organization in the United States.
A lock (lock ) or https:// means you’ve safely connected to the .mil website. Share sensitive information only on official, secure websites.

Home : Media : News : News Article View
NEWS | March 22, 2021

COVID-19 Vaccines Shipped by COVAX Facility Arrive in Lao People’s Democratic Republic

U.S. Embassy in Laos

VIENTIANE, U.S. Embassy in Laos -- Lao PDR today received its first shipment of COVID-19 vaccine doses through the COVAX facility, a partnership between the Coalition for Epidemic Preparedness Innovations (CEPI), Gavi, the Vaccine Alliance, UNICEF and the World Health Organization (WHO).

The shipment consists of 132,000 doses of the AstraZeneca/Oxford vaccine, manufactured by the Serum Institute of India (SII), and was shipped by air to the Wattay International Airport in Vientiane from Pune, India. This batch of AstraZeneca/Oxford vaccines is the first of the total of 480,000 doses being planned for delivery to Lao PDR via the COVAX initiative this year to cover about 20 percent of the total population.

“I would like to extend my warmest gratitude to the COVAX facility and our partners, Gavi, UNICEF and WHO, for their tremendous and valuable support in procuring this latest batch of COVID-19 vaccines. With the arrival of this shipment of vaccines, Lao PDR takes another step forward in the battle against the COVID-19 pandemic,” remarked H.E. Associate Professor Dr. Bounkong Syhavong, Minister of Health.

According the country’s National Deployment and Vaccination Plan (NVDP), this initial batch of AstraZeneca/Oxford vaccines will be used by the Government of Lao PDR to first immunize priority groups in the country who are at greater risk of exposure to COVID-19 and those who are most likely to develop severe symptoms from infection.

This includes frontline healthcare workers, older adults above the age of 60 and people with underlying health conditions. Some essential workers will also be prioritized based on the nature of the job and high-risk of exposure to COVID-19 such as workers at points of entry and in quarantine centers.

In addition to the vaccines, Lao PDR received yesterday 84,000 syringes and 840 safety boxes as well procured by UNICEF, which will enable the Government of Lao PDR to commence its vaccination campaign targeting these priority groups.

“This is a landmark moment for Lao PDR and the COVAX Facility’s mission to help end the acute phase of the pandemic by enabling equitable access to these vaccines across the world,” stated Ms. Véronique Maeva Fages, Senior Country Manager for Country Programmers at Gavi, the Vaccine Alliance. “We would like to congratulate the Government of Lao PDR for their inspiring leadership and their commitment to protecting the Lao people during this pandemic. Gavi looks forward to these vaccines being made available to the people most at risk, as soon as possible,” Ms. Fages further added.

GAVI board members represented in Lao PDR include Australia, Canada, the European Commission, France, Germany, Japan, Korea, Luxembourg, Switzerland, the United Kingdom, and the United States of America.

Producing a vaccine against a previously unknown disease in less than a year is a major achievement for medical science globally. And making sure that every country in the world has a fair and equitable access to the vaccines through the COVAX facility is also an extremely important breakthrough.

The arrival of the vaccines provided by the COVAX Facility is a game changer for Lao PDR’s ongoing fight against the COVID-19 pandemic and shows what is possible when there is a spirit of solidarity among the international community to collectively address this common threat. These COVID-19 vaccines have been carefully reviewed by WHO and assessed for quality, safety and efficacy; we are so pleased that Lao PDR has access to these vaccines just one month following their Emergency Use Listing (EUL), said Dr. Mark Jacobs, WHO Representative to Lao PDR. ”

No country will be safe from the pandemic until all countries are protected. The arrival of the vaccines from COVAX in Lao PDR today is a step in the right direction towards this ultimate goal,” Dr. Jacobs explained The vaccines that will be used in Lao PDR have gone through a rigorous development and safety testing procedures, where the Ministry of Health – Food and Drug Department has assessed the evidence, benefits and risks. The AstraZeneca vaccine licensed to Serum Institute of India provided through the COVAX was authorized for emergency use by the Ministry of Health on 22 February, after being listed for emergency use by WHO on 15 February.

This is truly a momentous occasion for Lao PDR and marks a major milestone in ensuring fairer access to vaccines globally. UNICEF is proud to be playing a leading role in supplying COVID-19 vaccines to Lao PDR and contributing to strengthening the country’s capacity to handle the pandemic, stated Dr. Pia Rebello Britto, UNICEF Representative to Lao PDR. “We are especially grateful to all partners for their significant contributions to GAVI and COVAX that have made possible the delivery of vaccines to Lao PDR. As the largest procurer of vaccines to Laos, for over a decade, UNICEF is aware of the critical role of such partnerships in delivering life-saving supplies for children,” Dr. Britto added.

The arrival of the vaccines in Lao PDR marks a key milestone for the COVAX facility in its unprecedented effort to deliver at least 2 billion doses of COVID-19 vaccines by the end of 2021, in what will be the largest vaccine procurement and supply operation in
history.

COVAX is co-led by Gavi, the Vaccine Alliance, the World Health Organization (WHO) and the Coalition for Epidemic Preparedness Innovations (CEPI), working in partnership with UNICEF as well as the World Bank, civil society organizations, manufacturers, and others. COVAX is part of the Access to COVID-19 Tools (ACT) Accelerator, a ground- breaking global collaboration to accelerate development, production, and equitable access to COVID-19 tests, treatments, and vaccines.

COVAX has built a diverse portfolio of vaccines suitable for a range of settings and populations, and is on track to meet its goal of delivering at least 2 billion doses of vaccine to participating countries around the globe in 2021, including at least 1.3 billion donor-funded doses to the 92 lower-income COVAX Facility participants supported by the Gavi COVAX Advance Market Committee (AMC).

CONNECT WITH USINDOPACOM
Facebook

Like Us
Twitter
337,788
Follow Us

ENGAGE & CONNECT MORE WITH PACOM

                                                 

IN THE USINDOPACOM NEWS
U.S. Indo-Pacific Commander Strengthens Cooperation in Visit to Timor-Leste
U.S. Indo-Pacific Commander Strengthens Cooperation in Visit to Timor-Leste
Feb. 3, 2023 - Adm. John C. Aquilino, Commander of U.S. Indo-Pacific Command, visited Timor-Leste Feb. 1-3, to strengthen our security cooperation and enduring partnership between our countries.In meetings with President José Ramos-Horta,...

7th Fleet Travels to the Republic of Korea for 7th Annual Anti-Submarine Warfare Cooperation Committee Meeting
BUSAN, Republic of Korea (Feb. 2, 2023) Vice Admiral Kim Jung-soo, Commander Republic of Korea Fleet leads Vice Adm. Karl Thomas, Commander, US 7th Fleet and Staff on a tour of the flight deck aboard the Republic of Korea Navy Dokdo-class Amphibious Assault Ship ROKS Marado (LPH-6112) in Busan, ROK. Vice Adm. Thomas is in the Republic of Korea to attend the 7th annual Anti-submarine Warfare Cooperation Committee meeting. (Courtesy photo by Commander, ROK Fleet Public Affairs)
Feb. 3, 2023 - BUSAN, Republic of Korea - Vice Adm. Karl Thomas, commander, U.S. 7th Fleet, visited Commander, Republic of Korea Fleet (CRF) Base in Busan, Republic of Korea (ROK), Feb. 2, to attend the 7th Anti-Submarine Warfare...

B-1B Lancers return to Indo-Pacific for BTF missions
A U.S. Air Force B-1B Lancer assigned to the 34th Expeditionary Bomb Squadron, prepares to take off from Ellsworth Air Force Base, South Dakota for a Bomber Task Force deployment, Jan. 31, 2023. BTF deployments are designed to showcase the Air Force’s ability to deter, deny and dominate any influence or aggression from adversaries or competitors. (U.S. Air Force photo by Staff Sgt. Jake Jacobsen)
Feb. 3, 2023 - B-1B Lancers assigned to the 34th Expeditionary Bomb Squadron from Ellsworth Air Force Base, South Dakota landed at Andersen Air Force Base, Guam, Feb 1...

Unified Pacific Intel Wargame “Pacific Winds” offers key insights to deter potential adversaries and address global challenges
Australian Army Maj. Gen. Chris Smith, U.S. Army Pacific Deputy Commanding General Strategy and Plans (right), and New Zealand Army Brig. Gen. Rose King, New Zealand Army Deputy Chief of Staff (center), listen to a brief during the Unified Pacific Wargame Series intelligence-focused
Feb. 2, 2023 - U.S. Army Pacific Commanding General Gen. Charles A. Flynn hosted senior leaders from across the Department of Defense and several allied nations as part of the Unified Pacific Wargame Series intelligence-focused event...

Austin Visit to Philippine Base Highlights Benefits of U.S-Philippine Alliance
Secretary of Defense Lloyd J. Austin III meets with Philippine Chief of Defense, Gen. Andres Centino at Camp Navarro, Zamboanga, Philippines, Feb. 1, 2023. Austin is traveling to Asia to meet with senior government and military leaders in Korea and the Philippines to advance regional stability, further strengthen the defense partnerships and reaffirm the deep commitment of the United States to work in concert with allies and partners in support of the shared vision of preserving a free and open Indo-Pacific.
Feb. 2, 2023 - Secretary of Defense Lloyd J. Austin III visited Camp Navarro in Mindanao, Philippines, where U.S. and Philippine service members are working closely together to ensure long-term prosperity of the region...